Wegovy results: the weight loss timeline
Month-by-month, from the first injection to the year-one plateau
Quick read · 5 min
In the STEP 1 trial, people on semaglutide 2.4mg weekly lost an average of 14.9% of their starting body weight over 68 weeks. That is roughly 34 lbs for a 230-lb person. But the loss is not evenly spread — the first 6–8 weeks feel slow, months 2–8 are the steepest part of the curve, and most people plateau somewhere between month 9 and month 12.
- •Average total loss: 14.9% of starting body weight at 68 weeks
- •First 4 weeks: 2–5 lbs (appetite change, some water weight)
- •Months 2–6: the fastest phase — most people lose 8–12% here
- •Months 6–12: slower burn, reaching the final 3–5%
- •Most people plateau by month 12 and maintain at that level
- •Roughly 1 in 3 people lose 20% or more (strong responders)
Based on clinical trials · No rankings · Every claim linked to source
The shape of the weight loss curve
Slow start, steep middle, gradual plateau. This is the average curve from STEP 1 trial.
Source: STEP 1 trial (Wilding et al., NEJM 2021) — 1,961 participants, 68 weeks, semaglutide 2.4mg weekly vs placebo
Milestones: real pounds at each point
Averages from trial data. Individual results vary, but these give you a realistic picture of what to expect.
Weights rounded to the nearest pound. Based on starting weights of 200 lb and 250 lb.
The four phases of the year
Knowing where you are in the arc helps you manage expectations — and stops you from panicking when the scale stalls.
- •Typical loss: 2–5 lbs
- •You are still titrating up — the dose is not yet clinically active
- •Appetite starts to shift, food noise may quieten
- •Side effects (nausea, fatigue) often peak here
- •Do not measure success yet
- •The fastest phase — most of your total loss happens here
- •You have reached a clinically active dose
- •Typical loss: 1.5–2.5 lbs per week on average
- •Scale drops are less linear — some flat weeks are normal
- •This is when clothes start fitting differently
- •Loss slows to 0.5–1 lb per week on average
- •You are chasing the last few percentage points
- •Resistance training and protein become more important
- •Small plateaus (1–3 weeks of no movement) are normal
- •Your maintenance identity starts to form
- •Weight stabilises — this is the new set point, not failure
- •Your body has adapted to a lower energy state
- •Staying on treatment keeps the weight off
- •Stopping typically means regaining 50–70% within a year
- •Long-term: most people maintain their loss on-drug
The first month: managing expectations
You are on the starting dose. That dose is not designed to cause weight loss — it is designed to let your gut adapt to the drug so you do not vomit for a week straight. Weight loss really begins when you reach the first clinically active dose, which is 4–12 weeks in depending on the drug.
The scale may still move 2–5 lbs in the first month, mostly from appetite reduction and water weight. That is normal and expected. The steep part of the curve comes later.
Not everyone gets the average
Trial averages hide a wide range. Here is how participants were distributed at 68–72 weeks.
lost 20% or more
lost 10% or more
lost 5% or more
Percentages overlap — a "10% responder" is also counted in the "5% responder" group.
Hitting the plateau
Keep reading
Based on clinical trials · No rankings · Every claim linked to source
Last reviewed: March 2026